147 related articles for article (PubMed ID: 18004592)
1. Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).
Salleras L; Domínguez A; Plans P; Costa J; Cardeñosa N; Torner N; Plasència A
Med Microbiol Immunol; 2008 Sep; 197(3):329-33. PubMed ID: 18004592
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes.
Salleras L; Domínguez A; Vidal J; Plans P; Salleras M; Taberner JL
Vaccine; 2000 Sep; 19(2-3):183-8. PubMed ID: 10930671
[TBL] [Abstract][Full Text] [Related]
3. Varicella-zoster virus immunity among health care workers in Catalonia.
Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of antibodies to varicella-zoster virus in Madrid (Spain) in the absence of vaccination.
Perez-Farinos N; Garcia-Comas L; Ramirez-Fernandez R; Sanz JC; Barranco D; Garcia-Fernandez C; Ordobas M
Cent Eur J Public Health; 2008 Mar; 16(1):41-4. PubMed ID: 18459480
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
Plans P; Costa J; Espuñes J; Plasència A; Salleras L
BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
[TBL] [Abstract][Full Text] [Related]
6. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students.
Mahamud A; Leung J; Masunu-Faleafaga Y; Teshale E; Williams R; Dulski T; Thieme M; Garcia P; Schmid DS; Bialek SR
Epidemiol Infect; 2014 May; 142(5):1002-7. PubMed ID: 23890292
[TBL] [Abstract][Full Text] [Related]
8. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
[TBL] [Abstract][Full Text] [Related]
10. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
Plans-Rubió P
Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
Lafer MM; de Moraes-Pinto MI; Weckx LY
Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
[TBL] [Abstract][Full Text] [Related]
12. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
13. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of varicella antibodies in adults without clinical history of disease.
Büchele KS; Correa DF; Tuyama M; Lemos ADS; Costa MDD; Mesquita EC; Costa DMD; Cerbino-Neto J; Varela MC; Brasil PEAAD; Brandão LGP
Cad Saude Publica; 2020; 36(1):e00149119. PubMed ID: 31967286
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of varicella-zoster virus in Polish population.
Siennicka J; Trzcińska A; Rosińska M; Litwińska B
Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey.
Kose S; Mandiracioglu A; Senger SS; Ulu Y; Cavdar G; Gol B; Gurbuz I; Sariavci S; Nohutcu N
J Infect Public Health; 2013 Apr; 6(2):115-9. PubMed ID: 23537824
[TBL] [Abstract][Full Text] [Related]
18. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil.
Semenovitch I; Lupi O
Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913
[TBL] [Abstract][Full Text] [Related]
19. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
20. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]